Harald Rupprecht, Lorenzo Catanese, Kerstin Amann, Felicitas E Hengel, Tobias B Huber, Agnieszka Latosinska, Maja T Lindenmeyer, Harald Mischak, Justyna Siwy, Ralph Wendt, Joachim Beige
Effective management of chronic kidney disease (CKD), a major health problem worldwide, requires accurate and timely diagnosis, prognosis of progression, assessment of therapeutic efficacy, and, ideally, prediction of drug response. Multiple biomarkers and algorithms for evaluating specific aspects of CKD have been proposed in the literature, many of which are based on a small number of samples. Based on the evidence presented in relevant studies, a comprehensive overview of the different biomarkers applicable for clinical implementation is lacking...
March 26, 2024: International Journal of Molecular Sciences